Clinical Trial Update: Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of Mucinex 1200mg on mucociliary and cough clearance during acute respiratory infection has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• MUCINEX (guaifenesin)

Snippet

Sponsor: Reckitt Benckiser LLC | Conditions: Acute Respiratory Infection | Phase 2 | Status: COMPLETED | Results posted: 2012-10-08